Free Trial

BioStem Technologies (OTCMKTS:BSEM) Posts Quarterly Earnings Results, Misses Estimates By $0.35 EPS

BioStem Technologies logo with Medical background

Key Points

  • BioStem Technologies reported a quarterly earnings per share (EPS) of ($0.03), significantly missing the consensus estimate of $0.32 by ($0.35).
  • Following the earnings announcement, shares of BioStem Technologies traded down by 2.8%, reaching $10.38.
  • The company, with a market cap of $173.74 million, specializes in developing pharmaceutical and regenerative medicine products, particularly using biologic stem cell alternatives.
  • Need better tools to track BioStem Technologies? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

BioStem Technologies (OTCMKTS:BSEM - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.32 by ($0.35), Zacks reports.

BioStem Technologies Trading Down 2.8%

Shares of OTCMKTS:BSEM traded down $0.30 during mid-day trading on Thursday, reaching $10.38. The stock had a trading volume of 24,490 shares, compared to its average volume of 59,922. The company has a market cap of $173.74 million, a P/E ratio of 7.06 and a beta of -0.29. BioStem Technologies has a 1 year low of $6.95 and a 1 year high of $28.26. The business's 50 day moving average price is $12.10 and its 200 day moving average price is $12.33.

About BioStem Technologies

(Get Free Report)

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.

Featured Stories

Earnings History for BioStem Technologies (OTCMKTS:BSEM)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in BioStem Technologies Right Now?

Before you consider BioStem Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BioStem Technologies wasn't on the list.

While BioStem Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines